Oyster cracker recall: FDA escalates recall to Class II amid potential presence of 'foreign material'
A food manufacturer is over 15,000 packages of oyster crackers sold at Target, Walmart and other stories due to the discovery ...
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
FingerLakes1.com2h
FDA issues Class II recall for International Delight coffee creamers
The Food and Drug Administration has issued a Class II recall for certain International Delight coffee creamers after reports ...
CURE3h
FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
MPR1h
FDA Determines REMS No Longer Necessary for Tryvio
The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...
The Manila Times8h
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...
Wing Sauce Recalled In 16 States As FDA Issues Risk Warning
A garlic wing sauce has been recalled across 16 states and given a risk classification after customers raised concern about ...
Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
The Manila Times6h
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
PEP-Therapy is a Paris-based clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, lead drug candidate, is a pro-apoptotic agent currently ...
FDA recall: 2 popular coffee creamers sold in Mississippi are making people sick. Did you buy?
International Delight coffee creamer sold in Mississippi now under FDA recall. Did you buy them? Are they in your home? What ...
The Cardiology Advisor5d
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...